Applied dna sciences, inc. terminates exclusive patent and know-how licensing and cooperation agreement with etch biotrace s.a

On december 4, 2019, applied dna sciences, inc. terminated its exclusive patent and know-how licensing and cooperation agreement (the “agreement”), dated march 28, 2019, with etch biotrace s.a., a wholly-owned subsidiary of theracann international benchmark corporation (“theracann”). the company terminated the agreement on the basis of theracann’s failure to pay in accordance with the terms of the agreement.
APDN Ratings Summary
APDN Quant Ranking